Therefore, in cells not constitutively overexpressing PD-L1 due to oncogenic mutation, PD-L1 expression levels can act as a surrogate marker of the presence of activated T cells that recognize cognate tumour antigen expression on cancer cells and release interferon-γ [59]. Here, CD274 is linked to cancer.